SuperTrans Medical (STM) is a late pre-clinical stage biopharmaceutical company developing novel antibiotics that target resistant bacteria.
STM is revitalizing and improving the properties of existing, FDA-approved drugs by chemical conjugation to its unique transporter technology.
The R&D team includes Dr. Lewis Neville, CEO, Dr. Jacob Rendell, CTO (Ex-Teva), Dr. Patricia Bradford (Ex-Wyeth, Novartis and AstraZeneca), D...
SuperTrans Medical (STM) is a late pre-clinical stage biopharmaceutical company developing novel antibiotics that target resistant bacteria.
STM is revitalizing and improving the properties of existing, FDA-approved drugs by chemical conjugation to its unique transporter technology.
The R&D team includes Dr. Lewis Neville, CEO, Dr. Jacob Rendell, CTO (Ex-Teva), Dr. Patricia Bradford (Ex-Wyeth, Novartis and AstraZeneca), Dr. Joseph Vacca (Ex-Merck and WuXi Apptec), Dr Peter Warn (Ex-Evotec) and Prof. Itamar Shalit, a pediatric clinical infectious diseases specialist.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.